Vedanta Biosciences' Series C Round

Vedanta Biosciences raised a round of funding on December 24, 2018.

Vedanta Biosciences is a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria.…

Articles about Vedanta Biosciences' Series C Round: